Get started
Author

Ramaswamy Sundararajan

Observed name: R Sundararajan
ORCID: 0000-0002-9169-6036
Observed ORCID: 0000-0002-9169-6036
OpenAlex ID: A5066683060
Bowel ischemia in COVID‐19: A systematic review
2021 · Suyog Patel, Charmy Parikh, et al. · International Journal of Clinical Practice · 31
PDF
Advantages and Disadvantages of Using St. John's Wort as a Treatment for Depression
2022 · Johanna S Canenguez Benitez, Tabata E Hernandez, et al. · Cureus · 22
PDF
Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study
2024 · Nabeel Khan, Ramaswamy Sundararajan, et al. · The American Journal of Gastroenterology · 7
Comparative Risk of Serious Infections Associated With Treatment of Inflammatory Bowel Disease
2025 · Nabeel Khan, Ramaswamy Sundararajan, et al. · Inflammatory Bowel Diseases · 6
Incidence of Pneumonia, Related Hospitalization, and Mortality Among Younger Unvaccinated IBD Patients in a Nationwide Cohort
2023 · Nabeel Khan, Chinmay Trivedi, et al. · Journal of Clinical Gastroenterology · 5
Incidence of Long COVID and Impact of Medications on the Risk of Developing Long COVID in a Nationwide Cohort of IBD Patients
2022 · Nabeel Khan, Nadim Mahmud, et al. · Clinical Gastroenterology and Hepatology · 5
PDF
Nephrotic syndrome following COVID-19 vaccination: a systematic review
2023 · Charmy Parikh, Henil Upadhyay, et al. · Journal of Nephrology · 3
An innovative concept book guide for MBBS students
2017 · Suhas Chandran, M. Kishor, et al. · Indian Journal of Psychiatry · 3
Long-Term Effectiveness and Safety of Tofacitinib in a Nationwide Veterans Affairs Cohort of Ulcerative Colitis Patients
2025 · Nabeel Khan, Ramaswamy Sundararajan, et al. · Crohn s & Colitis 360 · 2
Risk of severe and opportunistic infections and the impact of SARS‐COV‐2 on this risk in a nationwide cohort of patients with inflammatory bowel disease
2023 · Nabeel Khan, Nadim Mahmud, et al. · Alimentary Pharmacology & Therapeutics · 2
PDF
Adverse Events Related to SARS-CoV-2 Vaccine in a Nationwide Cohort of Patients With Inflammatory Bowel Disease
2022 · Nadim Mahmud, Walter Reinisch, et al. · Clinical and Translational Gastroenterology · 2
Incidence of Thiopurine-Induced Severe Myelosuppression in a Nationwide Cohort of Patients With Inflammatory Bowel Disease
2024 · Nabeel Khan, Dhruvan Patel, et al. · The American Journal of Gastroenterology · 1
P352 Occurrence of moderate to severe anaemia and utilization and efficacy of intravenous iron therapies in a nationwide cohort of Inflammatory Bowel Disease patients
2023 · N Khan, M Patel, et al. · Journal of Crohn s and Colitis · 1
PDF
Impact of Biologics on SARS-COV-2 Disease Course When Infused Within 2 Weeks of Acquiring the Infection Among IBD Patients
2022 · Nabeel Khan, Manthankumar Patel, et al. · Clinical Gastroenterology and Hepatology · 1
PDF
Adopted group therapy approach for coping with sadness among medical students
2020 · M Kishor, Preethi Prabhu, et al. · International Journal of Health & Allied Sciences · 1
Respiratory syncytial virus incidence and clinical outcomes in patients with inflammatory bowel disease: a National Veterans Affairs cohort study
2026 · Nabeel Khan, Ramaswamy Sundararajan, et al. · Inflammatory Bowel Diseases
Tu1502 PREDICTING THE CLINICAL COURSE OF NEWLY DIAGNOSED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE MACHINE LEARNING MODEL WITH EXTERNAL VALIDATION IN A MULTI-CENTER EUROPEAN INCEPTION COHORT
2026 · Hongzhe Zhang, Ramaswamy Sundararajan, et al. · Gastroenterology
Tu1502 PREDICTING THE CLINICAL COURSE OF NEWLY DIAGNOSED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE MACHINE LEARNING MODEL WITH EXTERNAL VALIDATION IN A MULTI-CENTER EUROPEAN INCEPTION COHORT
2026 · Hongzhe Zhang, Ramaswamy Sundararajan, et al. · Gastrointestinal Endoscopy
43 Reasons for Not Selecting an Anti-TNF in Bio-Naïve Patients With Inflammatory Bowel Disease: Results From a Nationwide VAHS Cohort and a National Survey
2025 · Nabeel Khan, Jae Rok Kim, et al. · The American Journal of Gastroenterology
Tu1823: CLINICAL COURSE OF RESPIRATORY SYNCYTIAL VIRUS INFECTION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
2025 · Ramaswamy Sundararajan, Freddy Caldera, et al. · Gastroenterology
S2476 Pancreatic Diffuse Large B-cell Lymphoma Presenting as Obstructive Jaundice
2024 · Ramaswamy Sundararajan, Samiran Mukherjee, et al. · The American Journal of Gastroenterology
Clinical Course of Bio Naive Ulcerative Colitis Patients Five Years After Initiation of Adalimumab in a Nationwide Cohort
2024 · Ramaswamy Sundararajan, Manthankumar Patel, et al. · Crohn s & Colitis 360
PDF
Sa1745 RISK OF SERIOUS INFECTIONS REQUIRING ICU ADMISSION ASSOCIATED WITH TREATMENT OF INFLAMMATORY BOWEL DISEASES
2024 · Nabeel H. Khan, Ramaswamy Sundararajan, et al. · Gastroenterology
S1190 5-Year Outcomes of Adalimumab Use in Nationwide Cohort of Bio-Naïve Ulcerative Colitis Patients
2023 · Ramaswamy Sundararajan, Manthankumar Patel, et al. · The American Journal of Gastroenterology
S1269 Racial Disparities in All-Cause Inpatient Endoscopic Retrograde Cholangiopancreatography in the United States: How Important Is Race?
2023 · Dushyant Singh. Dahiya, Ramaswamy Sundararajan, et al. · The American Journal of Gastroenterology
Works count: 34
Citation count: 92
H-index: 5
I10-index: 2
Year
Topic
Type